D. E. Shaw & Co., Inc. Novavax Inc Call Options Transaction History

D. E. Shaw & Co., Inc.

$98.6 Billion
Q2 2024

Call Options

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$3.89 - $20.97 $600,616 - $3.24 Million	154,400 Added 192.52%	234,600 $2.97 Million
Q1 2024 May 15, 2024	SELL	$3.76 - $6.02 $871,944 - $1.4 Million	-231,900 Reduced 74.3%	80,200 $383,000
Q3 2023 Nov 14, 2023	BUY	$6.81 - $9.74 $409,962 - $586,348	60,200 Added 23.9%	312,100 $2.26 Million
Q1 2023 May 15, 2023	SELL	$5.76 - $12.48 $3.26 Million - $7.06 Million	-566,000 Reduced 69.2%	251,900 $1.75 Million
Q4 2022 Feb 14, 2023	BUY	$8.86 - $25.04 $5.37 Million - $15.2 Million	605,900 Added 285.8%	817,900 $8.41 Million
Q3 2022 Nov 14, 2022	BUY	$18.2 - $76.12 $944,580 - $3.95 Million	51,900 Added 32.42%	212,000 $3.86 Million
Q2 2022 Aug 15, 2022	BUY	$36.28 - $75.29 $362,800 - $752,900	10,000 Added 6.66%	160,100 $8.23 Million
Q1 2022 May 16, 2022	SELL	$69.73 - $142.9 $216,163 - $442,990	-3,100 Reduced 2.02%	150,100 $11.1 Million
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $1.36 Million - $2.2 Million	-10,100 Reduced 6.18%	153,200 $21.9 Million
Q3 2021 Nov 15, 2021	SELL	$177.8 - $270.58 $7.65 Million - $11.6 Million	-43,000 Reduced 20.84%	163,300 $33.9 Million
Q2 2021 Aug 16, 2021	BUY	$121.0 - $257.67 $2.42 Million - $5.15 Million	20,000 Added 10.74%	206,300 $43.8 Million
Q1 2021 May 17, 2021	BUY	$112.98 - $319.93 $8.55 Million - $24.2 Million	75,700 Added 68.44%	186,300 $33.8 Million
Q4 2020 Feb 16, 2021	SELL	$78.74 - $139.5 $5.02 Million - $8.9 Million	-63,800 Reduced 36.58%	110,600 $12.3 Million
Q3 2020 Nov 16, 2020	BUY	$79.44 - $178.51 $9.88 Million - $22.2 Million	124,400 Added 248.8%	174,400 $18.9 Million
Q2 2020 Aug 14, 2020	BUY	$13.86 - $83.61 $693,000 - $4.18 Million	50,000 New	50,000 $4.17 Million

Others Institutions Holding NVAX

# of Institutions

284

Shares Held

83.2M

Call Options Held

5.43M

Put Options Held

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $935M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account